ArticleSensors (Basel, Switzerland)2025
A Linear and High-Sensitivity Microwave Biosensor on a FR-4 Substrate for Aqueous Glucose Monitoring Using a Concentric Square-Shaped Split-Ring Resonator.
Article in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Modified Single Metamaterial Split-Ring Resonator for Enhanced Sensitivity.Sensors (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Non-invasive glucose monitoring remains a significant challenge in diabetes management, with existing approaches often limited by poor accuracy, high cost, or patient discomfort. Microwave-based biosensors offer a promising label-free alternative by exploiting the dielectric contrast between glucose and water. This paper presents a compact, dual-band concentric square-shaped split-ring resonator (SRR-type) biosensor fabricated on a low-cost FR-4 substrate for aqueous glucose detection. The sensor leverages electric field confinement in inter-ring gaps to transduce glucose-induced permittivity changes into measurable shifts in resonance frequency and reflection coefficient. Experimental results demonstrate a linear, monotonic response across the clinical range up to 250 mg/dL, with a frequency-domain sensitivity of 1.964 MHz/(mg/dL) and amplitude-domain sensitivity of 0.0332 dB/(mg/dL), achieving high coefficients of determination (R
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.